Items tagged as "personalized medicine"
ROCHESTER, Minn. — Friday, April 25, is National DNA Day, the date which commemorates completion of the Human Genome Project, the national effort to identify and decode all 6 billion letters in human DNA. Since that time, medical researchers and practitioners have found new ways to apply genomics for everyone who [...]Created by Sam Smith
ROCHESTER, Minn. — It has been 1.5 years since Mayo Clinic opened the world’s first integrated multidisciplinary genomics service, the Individualized Medicine Clinic, which uses genomics and next-generation sequencing technologies to personalize treatments for patients with advanced cancer and complex diagnoses. In a special issue of the American Journal of [...]Created by Sam Smith
ROCHESTER, Minn. — Feb. 24, 2014 — Mayo Clinic researchers have fashioned a new key to unlocking the secrets of the human genome. The Binary Indexing Mapping Algorithm, version 3 (BIMA V3) is a freely available computer algorithm that identifies alterations in tumor genomes up to 20 times faster and [...]Created by Sam Smith
Study targets EGFR and FGFR cellular pathways to treat rare disease SCOTTSDALE, Ariz. — Feb. 13, 2014 — Physicians at Mayo Clinic’s Center for Individualized Medicine and researchers at the Translational Genomics Research Institute (TGen) have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies. Potential new treatment approaches are being [...]Created by Sam Smith
ROCHESTER, Minnesota — 21 de enero de 2014 — Los científicos de Mayo Clinic descubrieron una amplificación de HER2, conocida por conducir a algunos cánceres de mama, en un tipo de cáncer de vejiga llamado carcinoma urotelial micropapilar (MPUC, por sus siglas en inglés), y demostraron que la presencia de [...]Created by Soledad Andrade
ROCHESTER, Minn. ― Jan. 21, 2014 ― Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. [...]Created by Sam Smith
ROCHESTER, Minn. — The break neck pace of genomic discoveries has ushered in a new problem in the delivery of personalized medicine: comprehensive and consistent data reporting that will improve health information technologies for better patient care. Christopher G. Chute, M.D., of Mayo Clinic and Isaac Kohane, M.D., of Harvard [...]Created by mayonewsreleases